Serum Institute, Merck & IAVI tie up to develop Covid-19 treatment therapy

coronavirus study

Under IAVI’s agreement with Merck and Serum, the partners will conduct an accelerated, integrated program of preclinical and clinical research to evaluate the antibodies for treatment of Covid-19. Serum Institute of India has joined hands with Merck KGaA, Germany, and IAVI, a non-profit research organisation, to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs). This has been … Read more